Delivery Order SPE2DR25D2006-SPE2DR26F56PH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,798.06 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count units). This firm fixed-price delivery order, awarded on April 24, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of April 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,225.66 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units). This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, represents a non-set-aside competitive award. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a $22,501.62 delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) under a firm fixed-price contract. The order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded delivery order that represents a discrete transaction within...
- The Defense Logistics Agency awarded a $1,838.49 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall 10 mg tablets in quantities of 100. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a non-competitive set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $12,063.51 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall 10 mg tablets (100-count units), with an ultimate completion date of December 8, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $1,225.66 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Adderall 10 mg tablets in quantities of 100. This firm fixed-price contract, with an ultimate completion date of December 4, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,077.90 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 28, 2025. The award was issued on November 26, 2025, with performance to be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 30 mg tablets (100 count units) with a ceiling value of $6,187.04. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by December 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $14,584.76 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for 4,563,799,761 tablets of Adderall 20 mg with a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,278.00 to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100 count units) on November 14, 2025, with an ultimate completion date of November 17, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56PHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,646.74 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) under a firm fixed price contract. This non-set-aside delivery order, issued on December 8, 2025, with completion targeted for December 9, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier to federal medical procurement operations through its extensive portfolio of pharmaceutical products and medical supplies. This delivery order represents a task order issued against AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs globally. The arrangement allows DLA to efficiently source controlled pharmaceutical substances and other medical commodities through a pre-established vendor relationship, supporting Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.6k | 12/7/25 |